maraviroc

  1. C

    Maraviroc treatment for hospitalized participants with non-severe COVID-19…: a randomized, proof-of-concept clinical trial, 2025, Gasca-Capote et al.

    Abstract Background: Therapeutic options for hospitalized people with COVID-19 remain limited, especially for people with non-severe COVID-19 at risk of progression. The anti-inflammatory role of maraviroc, a CCR5 antagonists, makes it a good candidate for therapeutic strategies for COVID-19...
  2. forestglip

    Still to open [Tucson, Arizona, USA], Efficacy of Maraviroc and Atorvastatin for the Treatment of Subjects With Long COVID

    A Multi-Center Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Maraviroc and Atorvastatin for the Treatment of Subjects With Long COVID/Post-Acute Sequalae of Covid (PASC) Brief Summary The IMPACT Long Covid Treatment clinical study (IMPACT-LC) is testing two...
  3. forestglip

    Protocol Investigating the Feasibility of Repurposing HIV Antivirals in Adults With Long Covid [tenofovir/emtricitabine or maraviroc]

    Brief Summary The trial will test if two repurposed HIV antivirals can reduce symptom burden in adult participants with Long Covid compared to placebo. Viral infection and viral reactivation have been documented in Long Covid. Participants will be randomly allocated to receive antivirals, TDF...
Back
Top Bottom